Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Soft tissue sarcoma panel (12 genes) Molecular Genetics Laboratory North York General Hospital Canada | 2 | 12 |
|
SERPINE1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 110 | 112 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 78 | 79 |
|
Coagulation Factor Deficiency Panel PreventionGenetics, part of Exact Sciences United States | 21 | 20 |
|
Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Quest Diagnostics Nichols Institute San Juan Capistrano United States | 1 | 1 |
|
Plasminogen activator inhibitor-1 deficiency (sequence analysis of SERPINE1 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Plasminogen Activator Inhibitor 1 Polymorphism Duzen Laboratories Duzen BBAGUAS Turkey | 1 | 1 |
|
Genetiks Genetic Diagnosis Center Genetic Diseases Evaluation Center Turkey | 1 | 1 |
|
Comprehensive Bleeding Disorder Panel Versiti Diagnostic Laboratories Versiti, Inc United States | 80 | 66 |
|
Versiti Diagnostic Laboratories Versiti, Inc United States | 1 | 1 |
|
BioReference Health United States | 1 | 1 |
|
PathGroup United States | 4 | 3 |
|
Factor V Leiden Genotyping, MTHFR C677T and A1298C Genotyping, and SERPINE1 (PAI-1) 4G/5G Genotyping PathGroup United States | 4 | 3 |
|
Factor V Leiden Genotyping and SERPINE1 (PAI-1) 4G/5G Genotyping PathGroup United States | 2 | 2 |
|
MTHFR C677T and A1298C Genotyping and SERPINE1 (PAI-1) 4G/5G Genotyping PathGroup United States | 3 | 2 |
|
PathGroup United States | 6 | 4 |
|
Factor II (Prothrombin) G20210A Genotyping and SERPINE1 (PAI-1) 4G/5G Genotyping PathGroup United States | 4 | 2 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.